Background:
Interventional techniques for the treatment of spinal techniques are commonly used and are increasing exponentially. Epidural injections and facet joint interventions are the 2 most commonly utilized procedures in interventional pain management. The current literature regarding the effectiveness of epidural injections is sparse with highly variable outcomes based on the technique, outcome measures, patient selection, and methodology. Multiple reports have illustrated the exponential growth of lumbosacral injections with significant geographic variations in the administration of epidural injections in Medicare patients. However, an analysis of the growth of epidural injections and costs in the Medicare population has not been performed with recent data and has not been looked at from an interventional pain management perspective.
Study Design:
Analysis of epidural injection growth and costs in Medicare's population 1997, 2002, and 2006.
Objectives:
The primary purpose of this study was to evaluate the use of all types of epidural injections (i.e. caudal, interlaminar, and transforaminal in lumbar, cervical and thoracic regions), and other epidural procedures, including epidural adhesiolysis. In addition, the purpose was to identify trends in the number of procedures, reimbursement, specialty involvement, fluoroscopy use, and indications from 1997 to 2006.
Methods:
The Centers for Medicare and Medicaid Services (CMS) 5% national sample carrier claim record data from 1997, 2002, and 2006 was utilized.
Outcomes Assessment:
Outcome measures included Medicare beneficiaries' characteristics receiving epidural injections, epidural injections by place of service, type of specialty, reimbursement characteristics, and other variables.
Results:
Epidural injections increased significantly in Medicare beneficiaries from 1997 to 2006. Patients receiving epidurals increased by 106.3%; visits per 100,000 population increased 102.7%. Hospital outpatient department (HOPD) payments increased significantly; ASC average payments decreased; overall payments increased. The increase in procedures performed by general physicians outpaced that of interventional pain management (IPM) physicians.
Limitations:
Study limitations include no Medicare Advantage patients; potential documentation, coding, and billing errors.
Conclusions:
Epidural injections grew significantly. This growth appears to coincide with chronic low back pain growth and other treatments for low back pain. Since many procedures are performed without fluoroscopy, continued growth and inappropriate provision of services might reduce access.
Citing Articles
Spinal Cord Injury and Postdural Puncture Headache following Cervical Interlaminar Epidural Steroid Injection: A Case Report.
Park H, Kim H, Jeong S, Lee J, Choi S, Lee C
Medicina (Kaunas). 2022; 58(9).
PMID: 36143916
PMC: 9504657.
DOI: 10.3390/medicina58091237.
Rationale for fluoroscopic guidance in spine injections.
Stratchko L, Pitts J, Symanski J, Ross A, Davis K, Monroe E
Skeletal Radiol. 2022; 52(10):1841-1851.
PMID: 36102947
DOI: 10.1007/s00256-022-04181-8.
Effect of Previous Caudal Block to Predict Successful Outcome after Adhesiolysis using a Steerable Catheter in Lumbar Failed Back Surgery Syndrome: A Retrospective Study.
Kim J, Kim D, Han D, Kim Y, Lee J, Park Y
Int J Med Sci. 2022; 19(6):1029-1035.
PMID: 35813291
PMC: 9254364.
DOI: 10.7150/ijms.72272.
Predictive value of immediate pain relief after lumbar transforaminal epidural injection with local anesthetics and steroids for single level radiculopathy.
Germann C, Gotschi T, Sutter R
Skeletal Radiol. 2022; 51(10):1975-1985.
PMID: 35394165
PMC: 9381491.
DOI: 10.1007/s00256-022-04051-3.
Lumbar Spinal Steroid Injections and Infection Risk after Spinal Surgery: A Systematic Review and Meta-Analysis.
Patel H, Cheppalli N, Bhandarkar A, Patel V, Singla A
Asian Spine J. 2022; 16(6):947-957.
PMID: 35249315
PMC: 9827202.
DOI: 10.31616/asj.2021.0164.
To compare the analgesic efficacy of two different doses of epidural ketamine in chronic low back-pain patients: A randomised double-blind study.
Gupta R, Kaur H, Kaur S, Mahajan L, Kaur T
Indian J Anaesth. 2020; 64(9):768-773.
PMID: 33162571
PMC: 7641091.
DOI: 10.4103/ija.IJA_541_20.
A novel approach to neuraxial anesthesia: application of an automated ultrasound spinal landmark identification.
Oh T, Ikhsan M, Tan K, Rehena S, Han N, Sia A
BMC Anesthesiol. 2019; 19(1):57.
PMID: 30991949
PMC: 6469214.
DOI: 10.1186/s12871-019-0726-6.
Aggregation properties of triamcinolone acetonide injection in human serum: considerations when performing epidural steroid injections.
Wahezi S, Mohamed S, Lederman A, Beck A
J Pain Res. 2019; 12:1033-1039.
PMID: 30936741
PMC: 6430988.
DOI: 10.2147/JPR.S181038.
Pain reduction after lumbar epidural injections using particulate versus non-particulate steroids: intensity of the baseline pain matters.
Tagowski M, Lewandowski Z, Hodler J, Spiegel T, Goerres G
Eur Radiol. 2019; 29(7):3379-3389.
PMID: 30887207
DOI: 10.1007/s00330-019-06108-9.
An epidural steroid injection in the 6 months preceding a lumbar decompression without fusion predisposes patients to post-operative infections.
Donnally 3rd C, Rush 3rd A, Rivera S, Vakharia R, Vakharia A, Massel D
J Spine Surg. 2018; 4(3):529-533.
PMID: 30547115
PMC: 6261770.
DOI: 10.21037/jss.2018.09.05.
Examining the association of body mass index and the depth of epidural space, radiation dose exposure and fluoroscopic screening time during transforaminal nerve block injection: a retrospective cohort study.
Galbraith A, Wallace E, Devitt A
Ir J Med Sci. 2018; 188(1):295-302.
PMID: 29911292
DOI: 10.1007/s11845-018-1845-7.
Is there a difference in treatment outcomes between epidural injections with particulate versus non-particulate steroids?.
Bensler S, Sutter R, Pfirrmann C, Peterson C
Eur Radiol. 2016; 27(4):1505-1511.
PMID: 27436028
DOI: 10.1007/s00330-016-4498-9.
Safety of Epidural Corticosteroid Injections.
Pountos I, Panteli M, Walters G, Bush D, Giannoudis P
Drugs R D. 2015; 16(1):19-34.
PMID: 26715572
PMC: 4767721.
DOI: 10.1007/s40268-015-0119-3.
Epidural injection with or without steroid in managing chronic low back and lower extremity pain: ameta-analysis of ten randomized controlled trials.
Zhai J, Zhang L, Li M, Tian Y, Zheng W, Chen J
Int J Clin Exp Med. 2015; 8(6):8304-16.
PMID: 26309483
PMC: 4538092.
Chiropractic use in the Medicare population: prevalence, patterns, and associations with 1-year changes in health and satisfaction with care.
Weigel P, Hockenberry J, Wolinsky F
J Manipulative Physiol Ther. 2014; 37(8):542-51.
PMID: 25233887
PMC: 4186903.
DOI: 10.1016/j.jmpt.2014.08.003.
Management of sacroiliac joint disruption and degenerative sacroiliitis with nonoperative care is medical resource-intensive and costly in a United States commercial payer population.
Ackerman S, Polly Jr D, Knight T, Holt T, Cummings J
Clinicoecon Outcomes Res. 2014; 6:63-74.
PMID: 24596468
PMC: 3930483.
DOI: 10.2147/CEOR.S54158.
α-Lipoic acid and superoxide dismutase in the management of chronic neck pain: a prospective randomized study.
Letizia Mauro G, Cataldo P, Barbera G, Sanfilippo A
Drugs R D. 2014; 14(1):1-7.
PMID: 24477618
PMC: 3964291.
DOI: 10.1007/s40268-013-0035-3.
Comparison of the costs of nonoperative care to minimally invasive surgery for sacroiliac joint disruption and degenerative sacroiliitis in a United States Medicare population: potential economic implications of a new minimally-invasive technology.
Ackerman S, Polly Jr D, Knight T, Schneider K, Holt T, Cummings J
Clinicoecon Outcomes Res. 2013; 5:575-87.
PMID: 24348055
PMC: 3838760.
DOI: 10.2147/CEOR.S52967.
Prevalence of the fibromyalgia phenotype in patients with spine pain presenting to a tertiary care pain clinic and the potential treatment implications.
Brummett C, Goesling J, Tsodikov A, Meraj T, Wasserman R, Clauw D
Arthritis Rheum. 2013; 65(12):3285-92.
PMID: 24022710
PMC: 4345120.
DOI: 10.1002/art.38178.
Pathophysiology, diagnosis, and treatment of discogenic low back pain.
Peng B
World J Orthop. 2013; 4(2):42-52.
PMID: 23610750
PMC: 3631950.
DOI: 10.5312/wjo.v4.i2.42.